Bryce Point Capital LLC bought a new position in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 59,366 shares of the company's stock, valued at approximately $1,907,000. Keurig Dr Pepper makes up about 0.6% of Bryce Point Capital LLC's investment portfolio, making the stock its 17th biggest position.
A number of other hedge funds also recently bought and sold shares of the stock. Townsquare Capital LLC raised its stake in Keurig Dr Pepper by 38.4% in the third quarter. Townsquare Capital LLC now owns 15,407 shares of the company's stock valued at $577,000 after buying an additional 4,275 shares in the last quarter. Glenmede Trust Co. NA increased its holdings in shares of Keurig Dr Pepper by 1.9% in the 3rd quarter. Glenmede Trust Co. NA now owns 28,593 shares of the company's stock valued at $1,072,000 after acquiring an additional 524 shares during the last quarter. Captrust Financial Advisors raised its position in shares of Keurig Dr Pepper by 77.8% during the 3rd quarter. Captrust Financial Advisors now owns 54,941 shares of the company's stock worth $2,059,000 after acquiring an additional 24,034 shares in the last quarter. Erste Asset Management GmbH purchased a new stake in Keurig Dr Pepper during the third quarter worth approximately $6,066,000. Finally, Benjamin Edwards Inc. boosted its holdings in Keurig Dr Pepper by 39.0% in the third quarter. Benjamin Edwards Inc. now owns 16,725 shares of the company's stock valued at $627,000 after purchasing an additional 4,691 shares in the last quarter. Institutional investors and hedge funds own 93.99% of the company's stock.
Keurig Dr Pepper Stock Performance
NASDAQ KDP traded down $0.52 on Monday, hitting $33.29. 6,070,113 shares of the company's stock were exchanged, compared to its average volume of 9,734,406. The firm's 50-day moving average price is $33.05 and its two-hundred day moving average price is $33.43. Keurig Dr Pepper Inc. has a fifty-two week low of $30.12 and a fifty-two week high of $38.28. The firm has a market cap of $45.17 billion, a price-to-earnings ratio of 20.19, a P/E/G ratio of 2.42 and a beta of 0.54. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.53 and a quick ratio of 0.36.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last released its quarterly earnings results on Tuesday, February 25th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.57 by $0.01. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The business had revenue of $4.07 billion during the quarter, compared to the consensus estimate of $4.01 billion. During the same quarter in the previous year, the company posted $0.55 EPS. The business's revenue was up 5.2% on a year-over-year basis. On average, research analysts expect that Keurig Dr Pepper Inc. will post 1.92 EPS for the current year.
Keurig Dr Pepper Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be paid a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a yield of 2.76%. The ex-dividend date is Friday, March 28th. Keurig Dr Pepper's payout ratio is 87.62%.
Analyst Upgrades and Downgrades
KDP has been the topic of a number of research analyst reports. TD Cowen cut their price objective on shares of Keurig Dr Pepper from $39.00 to $36.00 and set a "hold" rating on the stock in a report on Wednesday, January 8th. Piper Sandler started coverage on shares of Keurig Dr Pepper in a research note on Tuesday, February 25th. They set a "neutral" rating and a $35.00 price target on the stock. Barclays set a $39.00 price objective on shares of Keurig Dr Pepper in a research note on Thursday, February 27th. Morgan Stanley upgraded Keurig Dr Pepper from an "equal weight" rating to an "overweight" rating and lifted their target price for the stock from $38.00 to $40.00 in a research report on Tuesday, April 1st. Finally, JPMorgan Chase & Co. upped their target price on Keurig Dr Pepper from $37.00 to $40.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. Five analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to MarketBeat.com, Keurig Dr Pepper has a consensus rating of "Moderate Buy" and a consensus price target of $38.38.
Check Out Our Latest Report on Keurig Dr Pepper
Insider Buying and Selling
In other news, insider Mary Beth Denooyer sold 12,000 shares of the company's stock in a transaction dated Tuesday, April 1st. The stock was sold at an average price of $34.78, for a total value of $417,360.00. Following the completion of the sale, the insider now owns 166,511 shares of the company's stock, valued at $5,791,252.58. This represents a 6.72 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Angela A. Stephens sold 7,350 shares of the company's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $34.17, for a total transaction of $251,149.50. Following the completion of the transaction, the vice president now owns 74,587 shares of the company's stock, valued at $2,548,637.79. This trade represents a 8.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 84,409,350 shares of company stock valued at $2,756,709,930. Insiders own 1.00% of the company's stock.
About Keurig Dr Pepper
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
See Also
Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
